Familial Breast Cancer Registry Program in Patients Referred to the Cancer Institute of Iran

被引:3
|
作者
Sabokbar, Tayebeh [1 ]
Khajeh, Elias [2 ,3 ]
Taghdiri, Foad [2 ,3 ]
Peyghambari, Vahideh [1 ]
Shirkoohi, Reza [1 ]
机构
[1] Canc Inst Iran, Canc Res Ctr, Dept Genet, Tehran, Iran
[2] Tehran Univ Med Sci, Students Sci Res Ctr, Tehran, Iran
[3] Tehran Univ Med Sci, ETDC, Tehran, Iran
关键词
Breast cancer; familial breast cancer; screening; registry program; BRCA1; MUTATIONS; EARLY-ONSET; HEREDITARY BREAST; HIGH-RISK; WOMEN; HISTORY; PREVALENCE; GENES; MANAGEMENT; GENETICS;
D O I
10.7314/APJCP.2012.13.6.2675
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Annually a considerable number of people die because of breast cancer, a common disease among women also in Iran. Identifying risk factors and susceptible people can lead to prevention or at least early diagnosis. Among susceptibility risks, 5-10% of patients have a family history predisposing factor which can influence the risk of incidence among the family. Having a registry program can be a more practical way to screen high risk families for preventive planning. Method: Based on inclusion criteria, a questionnaire was prepared and after a pilot study on a small number of patients, actual data were collected on 400 patients and processed in SPSS 16.0. Results: Totally, 28.2% of the patients were younger than 40 years old and 36.8% had the included criteria for familial breast cancer (FBC). 102 patient's samples could be compared for receptor presentation. Similar to other studies, the number of triple negative breast cancers increased as the age decreased. Conclusion: The high percentage of patients with FBC among 400 cases in this study demonstrates that in order to design an infrastructural diagnostic protocol and screening of patients with FBC, a precise survey related to frequency and founder mutations of FBC is needed nationwide.
引用
收藏
页码:2675 / 2679
页数:5
相关论文
共 50 条
  • [1] A cost-benefit analysis of genetic screening test for breast cancer in Iran
    Meshkani, Zahra
    Moradi, Najmeh
    Aboutorabi, Ali
    Farabi, Hiro
    Moini, Nazi
    BMC CANCER, 2024, 24 (01)
  • [2] Screening for familial cancer risk: Focus on breast cancer
    Rousset-Jablonski, Christine
    Gompel, Anne
    MATURITAS, 2017, 105 : 69 - 77
  • [3] Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases
    Kast, Karin
    Haefner, Julia
    Schroeck, Evelin
    Jahn, Arne
    Werner, Carmen
    Meisel, Cornelia
    Wimberger, Pauline
    BREAST CARE, 2022, 17 (02) : 153 - 158
  • [4] Familial Prevalence of Cancer in Iran: A General Population Estimate
    Moghimi-Dehkordi, Bijan
    Safaee, Azadeh
    Vahedi, Mohsen
    Pourhoseingholi, Mohamad Amin
    Pourhoseingholi, Asma
    Habibi, Manijeh
    Zali, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (01) : 289 - 295
  • [5] Tumor characteristics and prognosis in familial breast cancer
    Arpino, G.
    Pensabene, M.
    Condello, C.
    Ruocco, R.
    Cerillo, I.
    Lauria, R.
    Forestieri, V.
    Giuliano, M.
    De Angelis, C.
    Montella, M.
    Crispo, A.
    De Placido, S.
    BMC CANCER, 2016, 16
  • [6] The Value of a Second Opinion for Breast Cancer Patients Referred to a National Cancer Institute (NCI)-Designated Cancer Center with a Multidisciplinary Breast Tumor Board
    Denise Garcia
    Laura S. Spruill
    Abid Irshad
    Jennifer Wood
    Denise Kepecs
    Nancy Klauber-DeMore
    Annals of Surgical Oncology, 2018, 25 : 2953 - 2957
  • [7] Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany
    Vetter, Lisa
    Keller, Monika
    Bruckner, Thomas
    Golatta, Michael
    Eismann, Sabine
    Evers, Christina
    Dikow, Nicola
    Sohn, Christof
    Heil, Joerg
    Schott, Sarah
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (02) : 289 - 299
  • [8] Outcome of Breast Cancer in Iran: A Study of Tehran Cancer Registry Data
    Mousavi, Seyed Mohsen
    Mohagheghi, Mohammad Ali
    Mousavi-Jerrahi, Alireza
    Nahvijou, Azin
    Seddighi, Zahra
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (02) : 275 - 278
  • [9] Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry
    Mocci, Evelina
    Milne, Roger L.
    Yuste Mendez-Villamil, Elena
    Hopper, John L.
    John, Esther M.
    Andrulis, Irene L.
    Chung, Wendy K.
    Daly, Mary
    Buys, Saundra S.
    Malats, Nuria
    Goldgar, David E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 803 - 811
  • [10] Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
    Torphy, Robert J.
    Schulick, Richard D.
    SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (01) : 25 - +